Panelists: John L. Marshall, MD, Georgetown University; George Kim, MD, 21st Century Oncology; Kabir Mody, MD, Mayo Clinic Cancer Center; Eileen M. O

Listen as the panel discusses the strategy for getting molecular testing done. Is there any role for circulating markers in this patient population?   Listen here  . . .